Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Mediating effects of insulin resistance on the development of hypertension associated with elevated serum uric acid: a prospective cohort study

Abstract

Many studies have demonstrated that elevated serum uric acid independently increases the risk of developing hypertension. However, the role of insulin resistance in the relationship between serum uric acid and hypertension is still unelucidated. Based on a prospective cohort study, we aimed to examine the longitudinal link between serum uric acid and hypertension and whether this relationship was mediated by insulin resistance. Overall, 21,999 participants without hypertension or gout at baseline with a mean age of 46 ± 13 years in the Jinchang Cohort were included in our study. Adjusted Cox-regression analyses and mediation analyses were performed to assess the risk of hypertension by serum uric acid quartile distribution and whether insulin resistance mediated the association between serum uric acid and hypertension. During the first follow-up period, 3080 participants developed hypertension. After controlling for covariates, compared with the lowest quartile of serum uric acid, the risk of hypertension in the highest quartile was 1.21 (1.06, 1.38) in the overall population. The risks for males and females were 1.14 (1.00–1.29) and 1.30 (1.08–1.56), respectively. The correlation between serum uric acid and hypertension was especially observed in younger people (<30 years). The mediating effects of insulin resistance were 0.058 (0.051, 0.065), 0.030 (0.025, 0.036) and 0.056 (0.047, 0.065), and the proportions mediated were 39.73, 36.59 and 38.62% in the overall, male and female populations, respectively. Elevated serum uric acid levels are associated with an increased risk of incident hypertension, and insulin resistance may play a mediating role in the relationship between serum uric acid and hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Adjusted HRs for incident hypertension according serum uric acid concentration by restricted cubic spline model in Jinchang Cohort population.
Fig. 2: Sex subgroups analysis of SUA quartiles distribution and hazard ratios (HRs) of hypertension incidence in Jinchang Cohort population.
Fig. 3: Age subgroups analysis of SUA quartiles distribution and hazard ratios (HRs) of hypertension incidence in Jinchang Cohort population.
Fig. 4: Mediation effects of baseline insulin resistance (TyG) on the association between baseline SUA and follow-up hypertension in Jinchang Cohort population.

Similar content being viewed by others

References

  1. Yu TY, Jee JH, Bae JC, Jin SM, Baek JH, Lee MK, et al. Serum uric acid: a strong and independent predictor of metabolic syndrome after adjusting for body composition. Metab-Clin Exp. 2016;65:432–40.

    Article  CAS  Google Scholar 

  2. Mortada I. Hyperuricemia, type 2 diabetes mellitus, and hypertension: an emerging association. Curr Hypertens Rep. 2017;19:69.

    Article  Google Scholar 

  3. Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729–41.

    Article  CAS  Google Scholar 

  4. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759–66.

    Article  CAS  Google Scholar 

  5. Sung KC, Byrne CD, Ryu S, Lee JY, Lee SH, Kim JY, et al. Baseline and change in uric acid concentration over time are associated with incident hypertension in large Korean cohort. Am J Hypertens. 2017;30:42–50.

    Article  CAS  Google Scholar 

  6. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247–52.

    Article  CAS  Google Scholar 

  7. Cui L-F, Shi H-J, Wu S-L, Shu R, Liu N, Wang G-Y, et al. Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohort. Clin Rheumatol. 2017;36:1103–10.

    Article  Google Scholar 

  8. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102–10.

    Article  CAS  Google Scholar 

  9. Zhu Y, Hu Y, Huang T, Zhang Y, Li Z, Luo C, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447:707–14.

    Article  CAS  Google Scholar 

  10. Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Insulin resistance in hypertension and cardiovascular disease. Best Pr Res Clin Endoc Metab. 2006;20:355–67.

    Article  CAS  Google Scholar 

  11. Cassano V, Crescibene D, Hribal ML, Pelaia C, Armentaro G, Magurno M, et al. Uric acid and vascular damage in essential hypertension: role of insulin resistance. Nutrients. 2020;12:2509.

    Article  CAS  Google Scholar 

  12. Sun ZJ. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65:252–6.

    Article  CAS  Google Scholar 

  13. Hanan T, Lan L, Qu R, Xu Q, Jiang R, Na L, et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension. Hypertension. 2017;70:703–11.

    Article  Google Scholar 

  14. Bai Y, Yang A, Pu H, Dai M, Cheng N, Ding J, et al. Cohort profile: the China Metal-Exposed Workers Cohort Study (Jinchang Cohort). Int J Epidemiol. 2017;46:1095–6e.

    PubMed  Google Scholar 

  15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL JR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure—the JNC 7 Report. JAMA. 2003;289:2560–72.

    Article  CAS  Google Scholar 

  16. Alberti K, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus—provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.

    Article  CAS  Google Scholar 

  17. Zhu J-R, Gao R-L, Zhao S-P, Lu G-P, Zhao D, Li J-J. 2016 Chinese guidelines for the management of dyslipidemia in adults joint committee for guideline revision. J Geriatr Cardiol. 2018;15:1–29.

    Google Scholar 

  18. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304.

    Article  CAS  Google Scholar 

  19. Preacher KJ, Rucker DD, Hayes AF. Addressing moderated mediation hypotheses: theory, methods, and prescriptions. Multivar Behav Res. 2007;42:185–227.

    Article  Google Scholar 

  20. Wei F, Sun N, Cai C, Feng S, Tian J, Shi W, et al. Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study. J Transl Med. 2016;14:110.

    Article  Google Scholar 

  21. Nishio S, Maruyama Y, Sugano N, Hosoya T, Yokoo T, Kuriyama S. Gender interaction of uric acid in the development of hypertension. Clin Exp Hypertens. 2018;40:446–51.

    Article  CAS  Google Scholar 

  22. Qu LH, Jiang H, Chen JH. Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis. Ann Med. 2017;49:142–56.

    Article  CAS  Google Scholar 

  23. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87:1411–4.

    Article  CAS  Google Scholar 

  24. Yang T, Chu C-H, Bai C-H, You S-L, Chou Y-C, Hwang L-C, et al. Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study. Metab-Clin Exp. 2012;61:1747–55.

    Article  CAS  Google Scholar 

  25. Kuwabara M, Niwa K, Nishi Y, Mizuno A, Asano T, Masuda K, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res. 2014;37:785–9.

    Article  CAS  Google Scholar 

  26. Viazzi F, Rebora P, Giussani M, Orlando A, Stella A, Antolini L, et al. Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk. Hypertension. 2016;67:934–40.

    Article  CAS  Google Scholar 

  27. Loeffler LF, Navas-Acien A, Brady TM, Miller ER III, Fadrowski JJ. Uric acid level and elevated blood pressure in US Adolescents National Health and Nutrition Examination Survey, 1999-2006. Hypertension. 2012;59:811–U145.

    Article  CAS  Google Scholar 

  28. Kanbay M, Segal M, Afsar B, Kang D-H, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759–66.

    Article  CAS  Google Scholar 

  29. Yokoi Y, Kondo T, Okumura N, Shimokata K, Osugi S, Maeda K, et al. Serum uric acid as a predictor of future hypertension: stratified analysis based on body mass index and age. Prev Med. 2016;90:201–6.

    Article  Google Scholar 

  30. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69:928–33.

    Article  CAS  Google Scholar 

  31. Genovesi S, Brambilla P, Giussani M, Galbiati S, Mastriani S, Pieruzzi F, et al. Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age. J Hypertens. 2012;30:327–35.

    Article  CAS  Google Scholar 

  32. Zheng RJ, Mao YS. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16:175.

    Article  Google Scholar 

  33. Cassano V, Crescibene D, Hribal ML, Pelaia C, Armentaro G, Magurno M, et al. Uric acid and vascular damage in essential hypertension: role of insulin resistance. Nutrients. 2020;12:2509.

    Article  CAS  Google Scholar 

  34. Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, et al. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J. 2014;28:3197–204.

    Article  CAS  Google Scholar 

  35. Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol. 2015;31:631–41.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the graduate students of the Lanzhou University School of Public Health and the doctors of the Jinchuan Company Staff Hospital who have made significant contribution to the establishment of the Jinchang Cohort.

Funding

This work was supported by Belt and Road Special Project of Lanzhou University (2018ldbrzd008) and Natural Science Foundation of China (No. 81673248).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhiyuan Cheng.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, R., Bai, Z., Zhang, D. et al. Mediating effects of insulin resistance on the development of hypertension associated with elevated serum uric acid: a prospective cohort study. J Hum Hypertens 36, 760–766 (2022). https://doi.org/10.1038/s41371-021-00562-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-021-00562-z

Search

Quick links